Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma after nivolumab treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Relapsed or Refractory Hodgkin Lymphoma, Children | Phase 2 | Status: ENROLLING_BY_INVITATION